Association of maternal preconception blood pressure with preterm birth: a population-based cohort study

The association between maternal preconception blood pressure (BP) and preterm birth (PTB) is still unclear. The purpose of this study was to investigate the association between maternal preconception BP and PTB. This population-based cohort study included 715 984 Chinese women aged 20–49 years who participated in the National Free Preconception Health Examination Project and successfully had a singleton livebirth during 2014–2019 in Guangdong Province, China. Maternal preconception BP were measured by trained health workers. Multivariate logistic regression models and restricted cubic spline regressions were used to examine the association and dose–response relationship between maternal preconception BP and PTB, respectively. Maternal preconception hypertension was associated with the increased risk of PTB (adjusted odds ratios (aOR): 1.24; 95% CI: 1.14–1.34). Compared to women with normal preconception BP, the aORs for PTB were 1.09 (95% CI: 1.06–1.12), 1.24 (95% CI: 1.13–1.36), and 1.43 (95% CI: 1.15–1.79) for women with preconception elevated BP (120–139/ 80–89 mmHg, stage-1 hypertension (140–159/ 90–99 mmHg, and stage-2 hypertension (160–179/100–109 mmHg), respectively. According to the 2017 American College of Cardiology/American Heart Association criteria, maternal preconception elevated BP and hypertension were also significantly associated with an increased risk of PTB. Preconception systolic and diastolic BP showed a U-shaped (χ2 = 40.54; nonlinear P < 0.001) and linear (χ2 = 6.62; nonlinear P = 0.085) dose–response relationship with PTB, respectively. The association was modified by maternal age and preconception body mass index. These findings identify maternal preconception elevated BP and hypertension as a modifiable risk factor for PTB, providing evidence for future research studies, public health and clinical interventions.